T cell receptor β‐chain repertoire analysis reveals the association between neoantigens and tumour‐infiltrating lymphocytes in multifocal papillary thyroid carcinoma
Open Access
- 10 May 2017
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 141 (2) , 377-382
Abstract
To explore whether a few nonsynonymous somatic mutations could induce activation and proliferation of neoantigen‐specific tumour‐infiltrating lymphocytes (TILs) in tumours with low mutation rates, we analysed a patient with multifocal papillary thyroid carcinoma (seven noncontiguous cancer foci) to investigate the relationship between neoantigens and TILs. These seven foci had a few or no nonsynonymous somatic mutations; moreover, multiple loci had similar or different spectra of mutations. We used high‐throughput sequencing of the rearranged genes in T cell receptor β‐chain (TCRβ) to reveal the basic characteristics of T cells in seven tumour foci and matched adjacent normal tissue. We found that in multifocal papillary thyroid carcinoma the number of nonsynonymous somatic mutations was positively associated with oligoclonal TCRβ repertoire, and tumour foci with similar spectra of mutations had higher overlap of TCRβ repertoire. In conclusion, the number of nonsynonymous somatic mutations is small in tumours with low mutation rates but these mutations still play an important role in activating neoantigen‐specific TILs.Keywords
Funding Information
- Natural Science Foundation of Beijing Municipality (7171001)
- National Natural Science Foundation of China (81441078)
This publication has 17 references indexed in Scilit:
- Tumor- and Neoantigen-Reactive T-cell Receptors Can Be Identified Based on Their Frequency in Fresh TumorCancer Immunology Research, 2016
- Engineered T cells: the promise and challenges of cancer immunotherapyNature Reviews Cancer, 2016
- Neoantigen landscape dynamics during human melanoma–T cell interactionsNature, 2016
- Clonality analysis of multifocal papillary thyroid carcinoma by using genetic profilesThe Journal of Pathology, 2016
- Cancer immunotherapy targeting neoantigensSeminars in Immunology, 2016
- Cancer Immunotherapy: More Is (Much) BetterClinical Cancer Research, 2015
- Neoantigens in cancer immunotherapyScience, 2015
- High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanomaNature Medicine, 2014
- Cancer Immunotherapy Based on Mutation-Specific CD4+ T Cells in a Patient with Epithelial CancerScience, 2014
- T-cell antigen receptor genes and T-cell recognitionNature, 1988